Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
MacAdam, Heather
Zaoutis, Theoklis E.
Gasink, Leanne B.
Bilker, Warren B.
and
Lautenbach, Ebbing
2006.
Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use.
International Journal of Antimicrobial Agents,
Vol. 28,
Issue. 4,
p.
325.
D'Agata, Erika M. C.
Cataldo, Maria Adriana
Cauda, Roberto
and
Tacconelli, Evelina
2006.
The Importance of Addressing Multidrug Resistance and Not Assuming Single-Drug Resistance in Case-Control Studies.
Infection Control & Hospital Epidemiology,
Vol. 27,
Issue. 7,
p.
670.
Falagas, Matthew E.
Koletsi, Patra K.
Kopterides, Petros
and
Michalopoulos, Argyris
2006.
Risk Factors for Isolation of Strains Susceptible Only to Polymyxin among Patients with
Pseudomonas aeruginosa
Bacteremia
.
Antimicrobial Agents and Chemotherapy,
Vol. 50,
Issue. 7,
p.
2541.
D'Agata, Erika M. C.
Cataldo, Maria Adriana
Cauda, Roberto
and
Tacconelli, Evelina
2006.
The Importance of Addressing Multidrug Resistance and Not Assuming Single-Drug Resistance in Case-Control Studies.
Infection Control & Hospital Epidemiology,
Vol. 27,
Issue. 7,
p.
670.
Gasink, Leanne B.
Zaoutis, Theoklis E.
Bilker, Warren B.
and
Lautenbach, Ebbing
2007.
The categorization of prior antibiotic use: Impact on the identification of risk factors for drug resistance in case control studies.
American Journal of Infection Control,
Vol. 35,
Issue. 10,
p.
638.
Pogue, Jason M.
Paterson, David L.
Pasculle, A. William
and
Potoski, Brian A.
2007.
Determination of Risk Factors Associated With Isolation of Linezolid-Resistant Strains of Vancomycin-Resistant Enterococcus.
Infection Control & Hospital Epidemiology,
Vol. 28,
Issue. 12,
p.
1382.
Hamilton, Keith W.
Bilker, Warren B.
and
Lautenbach, Ebbing
2007.
Controlling for Severity of Illness in Assessment of the Association Between Antimicrobial-Resistant Infection and Mortality: Impact of Calculation of Acute Physiology and Chronic Health Evaluation (APACHE) II Scores at Different Time Points.
Infection Control & Hospital Epidemiology,
Vol. 28,
Issue. 7,
p.
832.
Hyle, Emily P.
Gasink, Leanne B.
Linkin, Darren R.
Bilker, Warren B.
and
Lautenbach, Ebbing
2007.
Use of different thresholds of prior antimicrobial use in defining exposure: Impact on the association between antimicrobial use and antimicrobial resistance.
Journal of Infection,
Vol. 55,
Issue. 5,
p.
414.
Lautenbach, Ebbing
2007.
Antimicrobial Resistance: Problem Pathogens and Clinical Countermeasures.
p.
61.
Kato, H.
Kato, H.
Iwashima, Y.
Nakamura, M.
Nakamura, A.
and
Ueda, R.
2008.
Inappropriate use of loperamide worsens Clostridium difficile-associated diarrhoea.
Journal of Hospital Infection,
Vol. 70,
Issue. 2,
p.
194.
Falagas, Matthew E.
Mourtzoukou, Eleni G.
Giannopoulou, Konstantina P.
Alexiou, Vangelis G.
and
Rafailidis, Petros I.
2008.
Matching Criteria in Case-Control Studies in the Field of Antimicrobial Resistance.
Microbial Drug Resistance,
Vol. 14,
Issue. 2,
p.
171.
Pop-Vicas, Aurora
Tacconelli, E.
Gravenstein, Stefan
Lu, Bing
and
D'Agata, Erika M. C.
2009.
Influx of Multidrug-Resistant, Gram-Negative Bacteria in the Hospital Setting and the Role of Elderly Patients With Bacterial Bloodstream Infection.
Infection Control & Hospital Epidemiology,
Vol. 30,
Issue. 4,
p.
325.
Montero, M.
Sala, M.
Riu, M.
Belvis, F.
Salvado, M.
Grau, S.
Horcajada, J. P.
Alvarez-Lerma, F.
Terradas, R.
Orozco-Levi, M.
Castells, X.
and
Knobel, H.
2010.
Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case–control study.
European Journal of Clinical Microbiology & Infectious Diseases,
Vol. 29,
Issue. 3,
p.
335.
Woeltje, Keith F.
and
Lautenbach, Ebbing
2011.
Informatics and Epidemiology in Infection Control.
Infectious Disease Clinics of North America,
Vol. 25,
Issue. 1,
p.
261.
Kritsotakis, E. I.
Tsioutis, C.
Roumbelaki, M.
Christidou, A.
and
Gikas, A.
2011.
Antibiotic use and the risk of carbapenem-resistant extended-spectrum- -lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study.
Journal of Antimicrobial Chemotherapy,
Vol. 66,
Issue. 6,
p.
1383.
Tuon, Felipe F.
Rocha, Jaime L.
Toledo, Paula
Arend, Lavinia N.
Dias, Camila H.
Leite, Talita M.
Penteado-Filho, Sergio R.
Pilonetto, Marcelo
and
Zavascki, Alexandre P.
2012.
Risk factors for KPC-producing Klebsiella pneumoniae bacteremia.
The Brazilian Journal of Infectious Diseases,
Vol. 16,
Issue. 5,
p.
416.
Siedelman, Loretta
Kline, Susan
and
Duval, Sue
2012.
Risk factors for community- and health facility–acquired extended-spectrum β-lactamase–producing bacterial infections in patients at the University of Minnesota Medical Center, Fairview.
American Journal of Infection Control,
Vol. 40,
Issue. 9,
p.
849.
Linkin, Darren R.
and
Lautenbach, Ebbing
2012.
Pharmacoepidemiology.
p.
827.
Schechner, Vered
Temkin, Elizabeth
Harbarth, Stephan
Carmeli, Yehuda
and
Schwaber, Mitchell J.
2013.
Epidemiological Interpretation of Studies Examining the Effect of Antibiotic Usage on Resistance.
Clinical Microbiology Reviews,
Vol. 26,
Issue. 2,
p.
289.
Ko, Daisik
Moon, Song Mi
Lee, Ji Sung
Park, Yoon Soo
and
Cho, Yong Kyun
2013.
Risk Factors of Nosocomial Bacteremia of Extended-spectrum β-Lactamase ProducingEscherichia coli.
Yeungnam University Journal of Medicine,
Vol. 30,
Issue. 2,
p.
83.